Clothing & Footwear
Segment 3: cell-based diagnostics (9 bn€ / 2011) Management
Managing Directors:
Dr. Valentin Kahl, Production, Finances, Organisation Dr. Roman Zantl, Sales, R&D
Planned Investment, Shareholders/Investors
Privately owned company. Founders are still holding 65%.
Business Field
ibidi is a leading supplier for functional cell-based assays and advanced products for cellular microscopy. ibidi is located in Martinsried, Germany, close to Munich. The US headquarters, ibidi LLC, is located in Verona, WI, near Madison.
Our mission is to enable our customers to achieve outstand- ing success and breakthroughs in life sciences, pharma, biotechnology and medical diagnostics. We thereby are helping to make improvements in life possible.
Dr. Roman Zantl Dr. Valentin Kahl
Profile
Year of establishment 2001 Number of employees 27 Equity (in m€) 1.099Financing needs (in m€) 4,000
Positive result since 2008
Revenues in 2009 (in m€) 2.216 Revenues in 2010 (in m€) 2.648 Revenues in 2011e (in m€) 2.800 Revenues in 2012e (in m€) 3.100
Contact
Contact person Dr. Valentin Kahl Phone +49-(0) 89-5 20 46 17-14 E-mail [email protected] Website www.ibidi.de Address Am Klopferspitz 19 82152 Martinsried Germany
ibidi GmbH
Biotechnology
range has been continuously expanded to include system components and photovoltaic project planning services. The Inventux Solutions GmbH has already completed turn- key photovoltaic plants with a cumulated volume of over 5 MWp. In 2010, Inventux has marketed 40 MWp and achieved an annual turnover of 61.6 m€ and positive EBITDA and EAT. Inventux has developed a broad range of proprietary technology, know-how and IP. It has developed its own back-end production line and operates inde- pendently from turn-key equipment providers. Full capacity utilization and constant improvement of production processes have led to competitive production costs with the potential to further reduce costs.
Management
Inventux relies on a highly experienced management team with a long-term track record in so- lar and a proven ability to develop within 18 months a start-up idea into a successful revenue generating compa-
ny with 270 employees. Inventux has fully implemented a Management Information System and an SAP ERP-System and has four testified annual financial statements. In 2009, Inventux received ISO 9001 certification. Prerequisites for growth have been put in place.
Planned Investment, Shareholders/Investors
Inventux has a concentrated shareholder structure. Share- holders comprise the executive board the management team, Capital Stage AG and Conetwork Erneuerbare Ener- gien Holding GmbH. Inventux plans to further expand pro- duction with the addition of another 120 MW solar module line to increase overall capacity to 150 MW. Total invest volume is about 130 m€. This expansion step will reduce production costs of the solar modules to below 0,5 €/Wp further strengthening Inventux` competitiveness.
Profile
Year of establishment 2007
Number of employees 270
Equity (in m€) 4.0
Financing needs (in m€) 30-40
Positive result since 2010
Revenues in 2009 (in m€) 22.5 Revenues in 2010 (in m€) 61.6 Revenues in 2011e (in m€) >50 Revenues in 2012e (in m€) >60
Contact
Contact person Oliver Rothe
Phone +49-(0) 30-62 64 06-0 E-mail [email protected] Website www.inventux.com Address Wolfener Str. 23 12681 Berlin Germany
Inventux Technologies AG
Renewable Energies
Business Field
Inventux Technologies AG is a Germany-based developer, manufacturer and distributor of silicon-based micromorph thin-film solar modules focussed on the residential and com- mercial scale rooftop market. Inventux was founded by the current management team in 2007 and is headquartered in Germany which is also home to the Company’s main manu- facturing facility. Inventux has built a European distribution network with local presence in the core markets of Germa- ny, Italy, France, Great Britain, Spain and South Europe. In 2010 Inventux has built up its own project business com - pany offering turn-key photovoltaic plants.
Strategic Market Position
Inventux markets its products directly to installation com- panies and developers and focusses in particular on the re- sidential and commercial rooftop market. Inventux’ product
Capital Seeking Companies
In the market segment of database and planning systems, Jedox is (according to the actual BARC BI Survey) the most innovative vendor with the lowest total costs, the highest business achievements rate, the fastest realtime analysis and the best support quality.
Currently more than 70 employees are working for Jedox. The headquarters are located in Freiburg, subsidiaries exist in Frankfurt, Hamburg and Paris. Furthermore over 50 part- ner companies are selling the Jedox products in Europe, the APAC area and in North and South America.
Management
Kristian Raue, CEO and Founder Matthias Krämer, CTO
Bernd Eisenblätter, COO (Sales & Marketing)
More information online:
www.jedox.com/en/about-jedox/management.html
Planned Investment, Shareholders/Investors
No acute funding needs, possible funding need in a range of 5 m€ to accelerate international growth.
Business Field
Jedox is a worldwide leading vendor of in-memory-based Business Intelligence Systems. Jedox is the pioneer in using parallel processors (GPUs) for in-memory OLAP- servers and with that provides an advantage in speed that is up to 100 times higher than comparable systems offered by IBM, SAP or Microsoft.
Strategic Market Position
The software is available as an open source as well as a premium version and is used by more than 10,000 compa- nies worlwide. The increase in sales of the last years has always been in the range of 50% (exception 2009: 15%). In the first half of 2011 a growth of more than 70% could be realized.
Jochen Lachnit, Vice President Finance Kristian Raue, CEO
Profile
Year of establishment 2002
Number of employees 70
Equity (in m€) 1,5
Financing needs (in m€) -
Positive result since k.A.
Revenues in 2009 (in m€) -
Revenues in 2010 (in m€) -
Revenues in 2011e (in m€) -
Revenues in 2012e (in m€) -
Contact
Contact person Jochen Lachnit Phone +49-(0) 7 61-1 51 47-2 42 E-mail [email protected] Website www.jedox.com Address Bismarckallee 7a 79098 Freiburg Germany
Jedox AG
IT-Services
Business Field
Established in 1999, JPK Instruments AG is a leading manufacturer of nano-analytical instruments on a global scale. These instruments enable access to previously unavailable levels of nanotechnology. The product portfolio includes systems for a wide range of applications in the areas of physics, chemistry and biology. JPK products are especially applied in the research of surfaces, material - properties and also nano-optics.
Strategic Market Position
Several times in the past years, Deloitte has named JPK as the fastest-growing company in the sector of nanotech - nology in Germany. The company commands a market share of more than 50 percent in Germany. JPK instruments are utilised in the most prestigious research institutes from all over the world and will also be used by industrial compa- nies in the future. The headquarters of JPK Instruments AG are located in Berlin, with branches in Dresden, Cambridge (UK), Paris, Tokyo and Singapore. Furthermore the com - pany maintains a global distribution network.
Management
Management consists of the founding team and has many years of experience and a high level of know-how in the area of technology.
Frank Pelzer, CEO René Grünberg, CFO Torsten Jähnke, CTO Jörn Kamps, COO
Planned Investment, Shareholders/Investors
Main shareholders/funding requirements. Management is the majority shareholder.
Profile
Year of establishment 1999
Number of employees 70
Equity (in m€) 2
Financing needs (in m€) -
Positive result since 2004
Revenues in 2009 (in m€) 8
Revenues in 2010 (in m€) 10
Revenues in 2011e (in m€) 12
Revenues in 2012e (in m€) -
Contact
Contact person Frank Pelzer
Phone +49-(0) 30-5 33 11 20 72 E-mail [email protected] Website www.jpk.com Address Bouchéstr. 12 12435 Berlin Germany
JPK Instruments AG
Nanotechnologie
From left to right.: Torsten Jähnke (CTO), Frank Pelzer (CEO), Jörn Kamps (COO), René Grünberg (CFO)
Capital Seeking Companies
Management
Lophius Biosciences has a very experienced management team with proven expertise in the biotech and diagnostic space. Dr. Michael Lutz as CEO has a well documented track record with respect to build-up of small to medium sized biotech companies. Additional management mem- bers include:
Dr. Ludwig Deml, CSO
Sabine Wahlländer, Head Sales & Marketing Dr. Marcus Hämmerle, Head Technical Operations Dr. Karl Kleine, Head Quality Management Dr. Nadja Prang, Head Business Development
Dr. Kornelia Schlombs, Project leader Molecular Biology Dr. Sascha Barabas, Project leader Cell Biology/Immu - nology
Planned Investment, Shareholders/Investors
Currently Lophius is strongly supported by local investors such as S-Refit (Lead Investor), High-tech Gründerfonds and Bayernkapital. The company has a financing need of about 1.5 m€ until break-even mid 2013.
Business Field
Lophius Biosciences develops and markets innovative T-cell-based diagnostic tests for diagnosis and therapy control in the areas of transplantation, infectious and auto- immune diseases. The tests are based on two proprietary technology platforms.
Strategic Market Position
Lophius Biosciences intention is to become one of the leading T-cell-based diagnostic products based on its proprietary technology platforms with a particular focus on Europe.
Dr. Michael Lutz, CEO
Profile
Year of establishment 2002
Number of employees 19
Equity (in m€) 0.8
Financing needs (in m€) 1.5
Positive result since -
Revenues in 2009 (in m€) 0.1
Revenues in 2010 (in m€) 0.03 Revenues in 2011e (in m€) 0.1 Revenues in 2012e (in m€) 1.0
Contact
Contact person Dr. Michael Lutz Phone +49-(0) 9 41-6 30 91 97-2 E-mail [email protected] Website www.lophius.de Address Josef-Engert-Str. 13 93053 Regensburg Germany
Lophius Biosciences GmbH
Biotechnology
sales engineer will assess the clients need and we will ma- nufacture the custom made products to the specific custo- mers physical security barrier needs. We have a number of patents and registered designs. We have an apetite for cus- tom solutions and are experts at product development. We are regarded as the experts in our field.
Management
Miklos Hegyi, Executive Director Adv. Tinus E. Lotz, Legal
Tertius Venter-Davies, Executive Director Renier Martin, Finance
Planned Investment, Shareholders/Investors
Maxidor has a well developed sub-assembly distribution strategy. The strategy has been implemented successfully in the factories in Cape Town and Durban as well as fran- chisees in four locations in South Africa and outside of South Africa in Ghana and Zimbabwe. This successful concept as well as the product range is well developed and ready for massive expansion. Maxidor has the logistical (Call centre in Johannesburg) and manufacturing infrastruc- ture. Capital is required to expand this concept into the rest of South Africa, Africa, South America (Brazil) and Europe. Worldwide people are under threat in their homes and places of work. This market is growing. Maxidor has had 25 years of experience in South Africa providing these solutions to individuals, families and companies. These principles, strategies and products have been tested and are ready to be implemented worldwide.
Profile
Year of establishment 1985
Number of employees 300
Equity (in m€) 2.5
Financing needs (in m€) 30
Positive result since 2002
Revenues in 2009 (in m€) 12
Revenues in 2010 (in m€) 12.1 Revenues in 2011e (in m€) 12.2 Revenues in 2012e (in m€) 12.8
Contact
Contact person Mr Miklos Hegyi
Phone +27-(0) 11-2 84-30 00
E-mail [email protected]
Website www.maxidor.com
Address 16 Arnold Street Alrode 1451 Johannesburg South Africa